CytRx Corp
CYTR
CYTR was delisted on the 3rd of June, 2019.
1 hedge funds and large institutions have $1 invested in CytRx Corp in 2022 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
50% less funds holding
Funds holding: 2 → 1 (-1)
100% less capital invested
Capital invested by funds: $2K → $1 (-$2K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CTA
Colonial Trust Advisors
Spartanburg,
South Carolina
|
-$1K |
CYTR Hedge Fund Activity: Q3 2022 in Review
1 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in CytRx Corp (CYTR) for Q3 2022, worth a combined $1 — down 100% from $2K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of CYTR and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Colonial Trust Advisors, exiting entirely with an estimated $1K sold.
- 1 institutional investor held CytRx Corp (CYTR) as of Q3 2022, down from 2 in Q2 2022.
- Funds reported $1 of CytRx Corp stock for Q3 2022, down 100% quarter-over-quarter.
- 0 funds opened new CytRx Corp positions in Q3 2022 and 1 closed out, a net change of -1 holder.
- The largest CytRx Corp seller in Q3 2022 was Colonial Trust Advisors, an estimated $1K sold.
Based on aggregated 13F filings for Q3 2022.